Intrauterine Spiral Can Reduce The Severity Of Menstrual Bleeding

Intrauterine Spiral Can Reduce The Severity Of Menstrual Bleeding.
Women with morose menstrual bleeding may get back some recess using an intrauterine device, or IUD, containing the hormone levonorgestrel, according to callow research. British researchers found that the treated IUD was more able at reducing the effects of heavy menstrual bleeding (also called menorrhagia) on worth of life compared to other treatments bestvito. Normally Euphemistic pre-owned for contraception, the intrauterine system is sold under the trade name name Mirena.

So "If women suffer with louring periods and do not want to get pregnant - as the levonorgestrel intrauterine pattern is a contraceptive - then having the levonorgestrel intrauterine system is a very first-rate first-line treatment option that does not require taking regular, daily vocal medications," said the study's lead author, Dr Janesh Gupta, professor of obstetrics and gynecology at the University of Birmingham and Birmingham Women's Hospital in England. For women who do want to get in the taking the blood-clotting medicament tranexamic acid during periods is an exchange methodology of treating heavy periods.

Results of the study, which was funded by the United Kingdom's National Institute of Health Research, appear in the Jan 10, 2013 end of the New England Journal of Medicine. Heavy menstrual bleeding is a significant facer for many women. About 20 percent of gynecologist responsibility visits in the United States and the United Kingdom are because of dreary bleeding. There are several nonhormonal and hormonal care options to hand to reduce blood loss.

The modish study compared the use of traditional medical options - tranexamic acid pills, mefenamic acid (Ponstel), combined estrogen-progestogen and progesterone singular - to the use of the levonorgestrel intrauterine system. The researchers randomly assigned nearly 600 women with cloudy menstrual bleeding to greet either the IUD or textbook medical care. They assessed gain using a patient-reported score on a lamella designed to measure severity of symptoms. The scale goes from 0 to 100, with turn down scores indicating more severe symptoms.